IPD impedimed limited

13.8%

3.3¢

Media, page-202

First 202 Last

Share
Profile

Follow
Steini

14,081 Posts.

4209

15/05/24

12:06

Post #: 73833695
Share

Originally posted by Twodogs196: ↑

and the very important detail that has been posted on here before about sales .. that seems to not be given enough weight to or be understood is that Ric was focussed on building internal Company systems and infrastructure .. not on sales.. he said that to a shareholders face... ask BBInvestorClub about the conversation they had ... so given that .. not sure how anyone can say/ask where are the sales ..?? its only since PB etc have reworked the entire sales approach which has only been in operation properly from after ASBS meeting in April .. ( thats code for actually having one .. I'd say lol to that but its not a laughing matter .. ) that we can now actually ramp up sales and $$$ .. which is why as Acclivity says above that the change to BOD etc had to happen .. or the Co would have been driven into the ground..

picture this ..

if Ric was going to spend $$ on internal systems building as he said .. which would clearly use cash at bank and also increase ongoing cash burn .. and not look to focus on sales .. how long till the almost G'teed next CR ..?? and at what price/capital dilution ..?? what would the share price be then ..??

the better way is underway .. what sales will we crack in this Qtr ..?? Sept Qtr looking better as there is time for all new actions to start having traction .. and Dec Qtr should be a Company best .. and onward from there..

stay tuned..

cheers all ..

Expand

The only way to silence the " Old Board Supporters " is by increasing revenue and to become profitable. Otherwise they will never stop questioning that the change was needed and good.

Looking forward to the January'25 4C as the criteria for the new board's / CEO effectiveness.

GLTA

IPD Price at posting: 8.0¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 202 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.3¢		Change 0.004(13.8%)		Mkt cap ! $66.90M

Open	High	Low	Value	Volume
3.0¢	3.3¢	2.9¢	$108.8K	3.507M

Buyers (Bids)

No.	Vol.	Price($)
1	50000	3.0¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	1063	1

View Market Depth

No.	Vol.	Price($)
1	50000	0.030
3	1445672	0.029
2	167894	0.028
5	635000	0.027
5	1619829	0.026

Price($)	Vol.	No.
0.033	1063	1
0.034	123000	1
0.035	335714	2
0.036	250000	1
0.037	100000	1

Last trade - 16.19pm 27/06/2025 (20 minute delay)

IPD (ASX) Chart

Media, page-202

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media, page-202

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News